A Phase I, multicenter, single-arm study to evaluate the pharmacokinetics, pharmacodynamics, and safety of crovalimab in patients with lupus nephritis
-
Autoimmune Disorder -
Lupus Nephritis
For the latest version of this information please go to www.forpatients.roche.com